Welcome! The Bloomington Life Sciences Partnership is a collaborative effort dedicated to continued life sciences business growth in greater Bloomington, Indiana - a nationally recognized leading metro area in medical devices, contract pharma, biotechnology, basic research and life sciences workforce development.

The Mill’s 2nd Annual INX Pitch Event Sends Five Qualifiers to Indy for INX

August 6, 2018 FOR IMMEDIATE RELEASE For more information, please contact: Pat East pat.east@cofoundventures.com 317.965.2155 Bloomington, Ind – Dimension Mill’s 2nd Annual INX Pre-Qualification Pitch Event was held on Wednesday, July 25th, 2018. Twelve pitches were presented at the event. Five were chosen to qualify for a trip to Indianapolis. Participants were given seven minutes to pitch their business, and seven minutes for a brief question and answer session led by the judges. The judges for this event were Mark Gramelspacher, EIR at Elevate Ventures;, the state’s venture capital fund Oscar Morales, Founder & Managing Director at VisionTech, the state’s largest angel group; and Teri Willey, Executive Director & Fund Manager at the IU Philanthropic Venture Fund, their new $15mm startup fund. The judges, prominent and respected investors in Indiana’s startup community, were impressed by the wide array of innovative companies that participated, and chose five winners from the twelve participants at the event. The five winners of the event, held at the Hoosier Energy complex in Bloomington, are a diverse set of companies that showcase the immense creativity of the startup community that The Mill plans to grow with its 19,000 square-foot facility, which seeks to be a hub of startup innovation and investment for Bloomington. The winners of the pre-qualification event were diverse in their solutions and showcased the immense amount of talent and innovation that exists within the Bloomington and area communities: Underdog Apparel, a company looking to create unique high-quality apparel for underserved collegiate markets; ShipperTech, which provides a secure solution to buyers and sellers in online marketplaces like Craigslist; The Bee Corp, which provides a unique data-driven solution for growers and beekeepers; Wave Therapeutics, which provides a solution to reduce and eliminate bedsores and discomfort for patients in nursing homes and other medical facilities; and Heliponix, which has developed the GrowPodTM , a device that can grow fresh, organic produce in the convenience of the customer’s home. “This year’s event could not have gone better! Good attendance, 12 solid pitches, smooth logistics, 5 winners instead of 2 last year, the Hoosier Energy venue was world-class and impressive, and the judges were professional investors and their questions, critiques, and coaching were exactly what our startups needed,” said Pat East, Executive Director of The Mill. The Mill is a 19,000 square-foot coworking, community collaboration, and high-potential startup business incubation space scheduled for completion on October 31st, 2018.   Please follow and like...

Read More

BioCrossroads accepting entries for 2018 new venture competition

Since 2012, BioCrossroads’ New Venture Competition has uncovered a steady stream of the most promising life sciences startups by offering awards, recognition and venture capital. To date, the competition has awarded more than $350,000 to 23 startup companies, which have successfully gone on to secure an additional $35 million in follow-on funding. “Through the competition, we have identified the next generation of life sciences start-ups – both from research done in academic settings as well as from entrepreneurs working independently and from all corners of Indiana.” said David Johnson, president and CEO, BioCrossroads. “It’s been gratifying to see some of our winners from a few years ago make progress.  SpeechVive and Diagnotes have products in the market; 2013 winner Spensa Technologies was acquired; and Scioto BioSciences, who won in 2016, just raised nearly $ 2 million in venture capital from investors including BioCrossroads.” In addition to a cash prize of $25,000 and exposure to hundreds of influencers at the Summit, the winners of the New Venture Competition will have access to the Indiana Seed Fund (ISF) staff and the fund’s network of resources to provide business planning and early-stage strategic support. They will also have the opportunity to make a presentation to the ISF investment committee for added exposure. Second and third place companies will be awarded cash prizes of $15,000 and $10,000 respectively. The Competition is open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus to Indiana. Startups will enter a highly competitive process with first round applications due Aug. 13, 2018. Five finalists will compete for cash prizes Oct. 9 during the 2018 Indiana Life Sciences Summit and be announced at the reception that evening at the Marriott Downtown Indianapolis. Taft Stettinius & Hollister LLP is the presenting sponsor. VisionTech Partners, Metazoa Brewing Company, Halo Capital Group and 16 Tech are also supporting the Competition through judging and sponsorships. For additional information and to apply, please visit www.biocrossroads.com/newventure About BioCrossroads BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow the life sciences, a public-private collaboration that supports the region’s research and corporate strengths while encouraging new business development.   BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises, expands collaboration and partnerships among Indiana’s life science institutions, expands science education and markets Indiana’s life sciences industry.  The initiative has formed several new nonprofit organizations, including Indiana Health Information Exchange, BioCrossroadsLINX, OrthoWorx, Datalys Center and the Indiana Biosciences Research Institute. Please follow and like...

Read More
Cook Group announcement expands life sciences industry in Bloomington
Sep19

Cook Group announcement expands life sciences industry in Bloomington

Bloomington, Ind. – Today, two Cook Group announcements mark significant, positive changes for the future of Bloomington. First, Cook Group and Catalent, Inc. announced a purchase agreement for Catalent (NYSE: CTLT) to purchase Cook Pharmica. In addition, Cook Group, through its subsidiary Cook Properties, has signed an agreement to purchase the former GE site near Cook’s world headquarters on Bloomington’s west side. “Both of these decisions will have a positive impact on our employees, our business and also on the local economy and workforce – creating new jobs, expanding the local life sciences industry, and attracting new talent to our region,” said Pete Yonkman, president of Cook Group and Cook Medical. “Today, more than ever, we are committed to Bloomington. It’s our home.” Cook Group and Catalent enter into purchase agreement for Cook Pharmica Catalent is a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Cook Pharmica expands Catalent’s capabilities by adding more drug substance and drug product expertise and capacity to serve patients world wide. Upon completion of the sale, Cook Pharmica and Catalent will create a new leader in the rapidly growing biologics development, analytical, manufacturing and finished product supply industry. “We only consider opportunities like this when it clearly benefits the patients we serve, our employees, the community, and both companies,” said Yonkman. “In this case, we feel confident that this is a good decision for all involved, including the more than 750 Cook Pharmica employees whose jobs are all secure. All of those employees will become part of Catalent’s growing biologics business and remain under the leadership of Cook Pharmica’s president, Tedd Green.” With Cook Pharmica’s available space and expertise, Catalent will create a biologics development and manufacturing center of excellence. The purchase allows Cook Pharmica to deepen relationships with customers and grow their already successful business. “This purchase is a recognition of the hard work, dedication, and community spirit of the men and women who have helped Cook Pharmica to grow. The Bloomington area has been a terrific home for this fast-growing business, and we look forward to further strengthening Cook Pharmica’s partnership with the community in the years to come,” said John Chiminski, president and CEO of Catalent. Catalent plans to invest aggressively in Cook Pharmica, and in the rest of the Catalent Biologics network to build a true global leader in the biologics market, which will help Catalent to improve the lives of patients around the world. The completion of the $950 million transaction is subject to customary closing conditions, including approval from regulatory authorities, and is expected to occur in the fourth...

Read More

AB BioTechnologies Breaks Ground on $10.5M Project

FOR IMMEDIATE RELEASE BLOOMINGTON, Ind. (May 31, 2017) – Construction has begun on a new 23,000-square foot pharmaceutical manufacturing facility for AB BioTechnologies in Monroe County. The company is a contract development and manufacturing organization (CDMO), and plans to add clinical and small-scale commercial manufacturing for injectable drugs later this year. AB BioTechnologies announced it was expanding in January and planning to hire over 30 positions over the next five years. The company was founded in 2008 by J. Jeff Schwegman, Ph.D. “Entrepreneurs and small businesses like AB BioTechnologies are driving economic growth and innovation in Indiana,” said Indiana Economic Development President Elaine Bedel. “Small businesses employ more than 1.2 million Hoosiers across the state, providing quality, good-paying jobs. As one of the Indiana companies recognized for its growth during Small Business Week in May, we look forward to watching AB BioTechnologies continue to expand and create new opportunities for Hoosiers.” “We are very grateful that AB Bio Technologies has chosen our community as the site for its innovation,” said Lynn Coyne, President of the Bloomington Economic Development Corporation. “We are proud to support their growth and bright future with the many resources in our area.” AB Biotechnologies received the Indiana Small Business Development Center 2017 Economic Development and Growth Through Entrepreneurship (EDGE) Award in small business earlier this month. About AB BioTechnologies Jeff Schwegman, Ph.D. founded AB BioTechnologies in February of 2008. Dr. Schwegman had more than 16 years of experience working in the contract development/manufacturing pharmaceutical industry before launching AB BioTechnologies, initially a teaching and consulting firm. AB BioTechnologies started small and budget efficient in the back bedroom of Dr. Schwegman’s home. In early 2010 the first small laboratory was opened, and the company quickly grew over the next few years tripling profits each year, adding new lab equipment, and going through two lab expansions to keep up with the demand for their services. For more information about AB BioTechnologies Inc., please visit www.ab-biotech.com. Please follow and like...

Read More
Sintact Medical Systems Receives National Science Foundation Small Business Innovation Research Grant
May11

Sintact Medical Systems Receives National Science Foundation Small Business Innovation Research Grant

Phase 2 grant will advance development of Sintact’s surgical film, to include seeking regulatory approval.   [Bloomington] – May 10, 2017 – Sintact Medical Systems, a startup developing an implantable film that prevents internal scar formation following cardiothoracic and neurological surgery, announced today it was awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase 2 grant worth approximately $750,000. Previously, Sintact Medical was awarded SBIR Phase 1 and 1B grants in July and December 2015. The collective funds will significantly advance testing and development of the non-resorbable film, culminating in a 510(k) regulatory submission.   “With the Phase 1/1B grant, we were able to conduct animal studies and prove the concept of our product,” said Sintact Medical CEO Erik Robinson. “We saw tremendous success with the first studies and are eager to continue developing and fine-tuning the film for commercialization. We appreciate the support from the National Science Foundation with this second grant and without them we would not be able to bringing our technology to market so quickly and ultimately improve patients’ lives.”   Phase 2 of the NSF SBIR grant program is designed as a “commercialization acceleration” grant, which can be matched by outside investment through the Phase 2B program. Sintact Medical will conduct pre-clinical testing and development, which align with feedback obtained through a Pre-Submission interaction from the FDA.   Sintact Medical’s technology was developed through Robinson’s doctoral work at Northwestern University in collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago, which demonstrated a reduction in scar formation in a pilot cardiothoracic animal study. Follow-on studies completed during Phase 1/1B validated the technology through expanded studies.   Phase 2 of the NSF SBIR grant ends March 31, 2019. Upon completion of Phase 2, Sintact Medical will report results to the agency and will rely on external private investment to continue commercialization efforts.   Sintact Medical has received support from organizations such as Health Wildcatters, VentureWell and iBIO Institute’s PROPEL Center, all of which have assisted and invested in the company’s success. For more information on Sintact Medical and its surgical film technology, visit sintactmed.com.   About Sintact Medical Systems Sintact Medical Systems, Inc. develops non-resorbable films that separate adjacent organs from adhering to each other after surgery. The Sintact Film™ acts as a scar preventative barrier separating organ and tissue surfaces to significantly reduce the likelihood of scar formation and the associated post-operative complications. Sintact Medical was founded by Erik Robinson, PhD and Gali Baler, PhD in 2013 as a result of the founders’ doctoral research at Northwestern University. For more information visit sintactmed.com. Please follow and like...

Read More
Indiana Ranked First in the Midwest for Business Second Year in a Row
May09

Indiana Ranked First in the Midwest for Business Second Year in a Row

INDIANAPOLIS (May 9, 2017) – Indiana ranked first in the Midwest and fifth in the nation for doing business by Chief Executive magazine, maintaining its position as a top state for business. The magazine’s “Best & Worst States For Business” ranking is based on surveys of more than 500 CEOs. According to Chief Executive, the results of the 13th annual survey show that CEOs favor states with friendly tax and regulatory climates, quality workforces and strong living environments, which includes cost of living, education and state and local attitudes toward business.  “Over the last 12 years, Indiana has worked to create a world-class economy by passing balanced state budgets, reducing regulatory burdens and investing in the future,” Governor Eric J. Holcomb said. “Today’s ranking reaffirms the benefits of our pro-business climate as we work to take Indiana to the next level.” As highlighted by Chief Executive, Indiana’s tax and regulatory policy ranks in the top 15 in the nation while the state’s workforce quality ranks in the top 10. The magazine highlighted Indiana’s focus on preserving and enhancing roads and bridges through Major Moves 2020 and recent legislation that will provide $1.2 billion in new annual funding by 2024 to support state and local infrastructure. As the Crossroads of America, this dedication to infrastructure will continue to strengthen Indiana’s competitiveness and quality of life by improving travel times for businesses, commuters and tourists.   Indiana’s ranking makes it the only Midwestern state in the publication’s top five. Among neighboring states, Ohio ranked No. 11, Kentucky ranked No. 22, Michigan ranked No. 36 and Illinois ranked No. 48.  The Chief Executive ranking comes on the heels of recent economic success stories in Indiana. Just last week, Infosys, a global technology firm, announced plans to establish a tech and innovation hub in central Indiana, investing $8.7 million and creating 2,000 high-skilled jobs over the next five years. Chief Executive magazine is a bi-monthly publication for top management executives published by the Chief Executive Group LLC. Founded in 1977, the Chief Executive Group LLC is headquartered in Greenwich, Connecticut. The full survey results are available online.  About IEDC The Indiana Economic Development Corporation (IEDC) leads the state of Indiana’s economic development efforts, helping businesses launch, grow and locate in the state. Governed by a 15-member board chaired by Governor Eric J. Holcomb, the IEDC manages many initiatives, including performance-based tax credits, workforce training grants, innovation and entrepreneurship resources, public infrastructure assistance, and talent attraction and retention efforts. For more information about the IEDC, visit www.iedc.in.gov.  – 30 – Media Contacts:  Abby Gras (IEDC) – 317.232.8845 or agras@iedc.in.gov Please follow and like...

Read More